Introduction
============

The taxonomy of *Giardia* has revealed six *Giardia* species: *G. lamblia* in mammals, including human; *G. agilis* in amphibians; *G. ardeae* and *G. psittaci* in birds; *G. microti* and *G. muris* in rodents ([@B1]). *G. lamblia* (synonym of *G. intestinalis* and *G. duodenalis*) is the most common intestinal protozoan parasite of a wide range of mammalian hosts and has a global distribution ([@B2], [@B3]). *G. lamblia* is a species complex with eight major genotypes or assemblages (A--H). Molecular characterizations based on multiple loci are used as the main tool to study genetic variation of different populations of *Giardia* ([@B4], [@B5]). Phylogenetic analysis using the small subunit ribosomal RNA (SSU-rDNA), glutamate dehydrogenase (*gdh*), beta-giardin (*bg*) and triose phosphate isomerase (*tpi*) genes have been used to study genetic variability and relations within assemblages of *G. lamblia* from different hosts. The *gdh* locus has been used to successfully genotype isolates of *G. lamblia* from a range of vertebrate hosts and it allows the discrimination between the various subgenotypes of *G. lamblia* assemblages ([@B6], [@B7]). In this study, glutamate dehydrogenase marker was used in the molecular characterization methods for genotyping and subtyping the isolates of *G. lamblia* from patients.

*G. lamblia* is one of the most common intestinal parasites in Iran. The prevalence of giardiasis varies in different parts of Iran (5%--23%) ([@B8]). Molecular epidemiology of human giardiasis is still unclear in Iran. Previously, there was no study performed using phylogenetic technique for *G. lamblia* in Iran. Only little information was available on the *G. lamblia* genotypes. Three studies based on PCR-RFLP assay, targeting the *gdh* gene of *G. lamblia* isolates genotype in Tehran, Shiraz and Isfahan provinces showed that assemblage A was the most prevalent ([@B9]--[@B11]). In contrast, two studies based on PCR-RFLP assay, targeting the *gdh* gene of *G. lamblia* isolates in Tabriz and in Uremia showed that assemblage B was the most prevalent genotype ([@B12], [@B13]).

Molecular studies on *G. duodenali* isolates and discrimination of genotypes is a useful way to know the transmission route and effective prevention management of giardiasis. The objective of this study was to determine genotyping and identify the sub-assemblages of *G. lamblia* isolates involved in the transmission of giardiasis in Fars Province, south of Iran. Genotypic characterization of the *gdh* gene was performed by using genomic DNA directly extracted from human fecal samples to evaluate the potential transmission routes of *G. lamblia* in this area.

Materials and Methods
=====================

Sample collection
-----------------

Forty *G. lamblia* isolates were collected from the patient's fecal samples with gastrointestinal discomfort referred to the health centers and hospitals in Shiraz, Fars Province, South of Iran in 2012. Then, the samples were sent to the Research Laboratory of Intestinal Protozoa in the Department of Parasitology and Mycology in School of Medicine at Shiraz University of Medical Sciences for further examination. Informed consent was taken from the patients and the study was approved by Ethics Committee of the university.

Purification technique
----------------------

Purification of *G. lamblia* cysts, which were to be used for DNA extraction, was done using the monolayer sucrose density gradient technique. Single step sucrose gradient with the specific gravity at 0.85 M was performed on positive stool samples in order to concentrate the cysts from fecal samples ([@B14]). Aliquots of the purified fecal samples were stored at 4 °C and −20 °C.

DNA extraction
--------------

The genomic DNA of *G. lamblia* was extracted using the Phenol-Chloroform-Isoamylalcohol (PCI) method with pretreatment by Triton X100 on purified fecal samples ([@B14]). DNA extracts were stored at −20 °C for PCR analysis.

PCR amplification of gdh gene
-----------------------------

A semi-nested PCR was performed using three primers known as GDHeF, GDHiF, and GDHiR that amplify a 432-bp fragment of the *gdh* gene ([@B7]) with some slight modifications. PCR reaction mixtures consisted of 12.5 pmol of each primer, 200 μmol of each dNTP, 1.5 mM of MgCl~2~, were carried out in 25 μl volumes on a Corbett Research Thermal Cycler, Australia with the following amplification conditions: one cycle of 94 °C for 2 min, 56 °C for 1 min and 72 °C for 2 min, followed by 31 cycles of 94 °C for 30 sec, 56 °C for 20 sec and 72 °C for 45 sec and a final extension of 72 °C for 7 min. Both positive and negative controls were included in each round of PCR to validate results. One microliter of PCR product from the primary reaction was added to the secondary PCR containing primers GDHiF and GDHiR. Reactions were visualized in UV on 1.5% agarose gels stained with ethidium bromide.

Sequence analysis of gdh gene
-----------------------------

Forty of the PCR products successfully amplified for the *gdh* locus were sent to First BASE Laboratories (<http://www.base-asia.com>) for commercial DNA sequencing reactions in both forward and reverse directions using primers GDHiF and GDHiR. Nucleotide sequences were analyzed using the computer program of sequencing scanner software. Multiple alignments and sequence alignment of these sequences were carried out using the BioEdit and the ClustalW MEGA4 programs. The *gdh* sequences of *G. lamblia* obtained in this study were aligned with previously published reference sequences of *G. lamblia* isolates from the GenBank database ([Table 1](#T1){ref-type="table"}). DNA sequencing of PCR products compared with already known *G. lamblia* sequences obtained from GenBank using ClustalW in the MEGA4. The accession numbers obtained for each reference assemblages from GenBank were L40509 (AI), L40510 (AII), AF069059 (BIII), L40508 (BIV), U60984 (C), U60986 (D), U47632 (E), AF069057 (F) and AF069058 (G) (5, 6, and 15). To determine similarities or homologies to known genes in NCBI GenBank sequence database, all obtained nucleotide sequences were submitted to BLAST searches. Sequence representatives for each of the assemblages identified in the studies were submitted to GenBank.

###### 

*Giardia gdh* gene sequences available in GenBank used in this study

  ***Isolate***   ***GenBank accession number***   ***Sub-assemblage***   ***Country***   ***Reference***
  --------------- -------------------------------- ---------------------- --------------- ------------------
  Ad-1            L40509                           AI                     Australia       ([@B6])
  Portland 1      M84604                           AI                     USA             ([@B16])
  Ad-1            AY178735                         AI                     Australia       Unpublished data
  F22             EF507606                         AI                     Brazil          ([@B17])
  Ad-2            L40510                           AII                    Australia       ([@B6])
  Ad-113          AY178736                         AII                    Australia       Unpublished data
  H32             EF507674                         AII                    Brazil          ([@B8])
  NLH20           AY826194                         AII                    Netherland      ([@B5])
  GH-125          AB195222                         AII                    Japan           ([@B18])
  TIG20           AB434776                         AII                    Iran            Unpublished data
  T11             JF968202                         AII                    Iran            Unpublished data
  16              JF917086                         AII                    Iran            Unpublished data
  Bah-12          AF069059                         BIII                   Australia       ([@B19])
  FCQ-21          AY178756                         BIII                   Australia       Unpublished data
  Cub-G89         EU594665                         BIII                   Cuba            ([@B20])
  Cub-G81         EU594667                         BIII                   Cuba            ([@B20])
  gd-ber9         DQ090540                         BIII                   Norway          ([@B21])
  gd-ber10        DQ090541                         BIII                   Norway          ([@B21])
  TIG12           AB434535                         BIII                   Iran            Unpublished data
  A14             JF968198                         BIII                   Iran            Unpublished data
  Ad-7            L40508                           BIV                    Australia       ([@B6])
  Ad-28           AY178738                         BIV                    Australia       Unpublished data
  Ad-45           AY178739                         BIV                    Australia       Unpublished data
  Ad-85           AY178755                         BIV                    Australia       Unpublished data
  NLH13           AY826191                         BIV                    Netherland      ([@B4])
  H30             EF507672                         BIV                    Brazil          ([@B17])
  GH-156          AB182126                         BIV                    Japan           ([@B22])
  GH-158          AB188825                         BIV                    Japan           ([@B23])
  Ad-141          U60984                           C                      Australia       ([@B15])
  Ad-148          U60986                           D                      Australia       ([@B15])
  P-15            U47632                           E                      Australia       ([@B24])
  Ad-23           AF069057                         F                      Australia       ([@B19])
  Ad-157          AF069058                         G                      Australia       ([@B19])
  *G. ardeae*     AF069060                                                Australia       ([@B19])

Phylogenetic analysis of gdh gene
---------------------------------

Phylogenetic analysis was performed using Neighbor-joining (NJ) method in the MEGA4 program. The evolutionary distance-based analysis was conducted using the Kimura 2-parameters model to estimates the distance among assemblages identified in this study. For each calculation, branch reliability was assessed using bootstrap analysis (1000 replicates). A neighbor-joining (NJ) tree composed of the 40-nucleotide sequences of *G. lamblia* isolates obtained in this study and 33 sequences of *G. lamblia* isolates of the *gdh* gene in the GenBank database ([Table 1](#T1){ref-type="table"}) was reconstructed. The homologous nucleotide sequence of *G. ardeae* (GenBank accession number AF069060) was used as outgroup.

Results
=======

PCR amplification of gdh gene
-----------------------------

The *Giardia gdh* locus with 432 bp was successfully amplified by semi-nested PCR. [Fig. 1](#F1){ref-type="fig"} shows a representative gel electrophoresis photograph of the PCR products amplified with *gdh* primers.

![Electrophoresis of PCR products with *gdh* primers (expected size of 432 bp) Lane 1 = Negative Control (primers + buffer) // Lane 2 = Positive control\
Lane 3--14 = *G. lamblia* isolates from patients // Lane M = 100 bp DNA marker (Fermentas, Canada)](IJPA-12-522-g001){#F1}

Sequence analysis of the gdh gene
---------------------------------

Sequence analysis was performed on 40 PCR products of *G. lamblia* based on *gdh* amplification both directions using GDHeF, GDHiF and GDHiR primers.

The genotyping results indicated the presence two main genotypes A and B of *G. lamblia*. Based on the DNAsequences of the glutamate dehydrogenase, 32 isolates (80%) were detected as assemblage A and 8 isolates (20%) were identical to assemblage B. After performing a BLAST search, analysis revealed all 32 isolates assemblage A sequences were 100% similar to sub-assemblage AII (GenBank Accession number L40510). From 8 isolates as assembalge B, three isolates were 99% similar to sub-assemblage BIII (GenBank Accession number AF069059), one isolate was 99% similar to sub-assemblage BIV (GenBank Accession number L40508) and four isolates were found between sub-assemblage BIII and BIV ([Table 2](#T2){ref-type="table"}). Comparison of *gdh* gene nucleotide substitutions between *G. lamblia* isolates obtained from this study and GenBank database published reference has shown in [Fig. 2](#F2){ref-type="fig"}.

![Sequence analysis for *gdh* gene nucleotide substitutions of *G. lamblia* isolates obtained from this study compared with reference sequences](IJPA-12-522-g002){#F2}

###### 

Genotyping characterization of 40 *G. lamblia* patients isolates from Fars Province, Iran

  ***Patient isolates***                                                                                                                                                                                                         ***Sub-assemblages***
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------
  32 *G. lamblia* isolates (GIS Group) (80%):                                                                                                                                                                                    AII (L40510)
  GIS1, GIS4, GIS7, GIS8, GIS9, GIS10, GIS11, GIS12, GIS13, GIS14, GIS15, GIS16, GIS17, GIS18, GIS19, GIS20, GIS21, GIS22, GIS24, GIS26, GIS27, GIS28, GIS29, GIS32, GIS33, GIS34, GIS35, GIS36, GIS37, GIS38, GIS39 and GIS40   
  3 *G. lamblia* isolates (7.5%):                                                                                                                                                                                                BIII (AF069059)
  GIS3, GIS23 and GIS25                                                                                                                                                                                                          
  1 *G. lamblia* isolates (2.5%):                                                                                                                                                                                                BIV (L40508)
  GIS5                                                                                                                                                                                                                           
  4 *G. lamblia* isolates (10%):                                                                                                                                                                                                 Between BIII & BIV
  GIS30, GIS31, GIS2 and GIS6                                                                                                                                                                                                    

Accession numbers for reference sequences obtained from GenBank are given in parentheses

Phylogenetic analysis of gdh gene
---------------------------------

Phylogenetic analysis of *gdh* DNA sequences was determined to further clarify the relationship of the different genotypes to each other. [Fig. 3](#F3){ref-type="fig"} shows the Phylogenetic tree based construction on the neighbor-joining method of the *gdh* sequences from *G. lamblia* of patients isolates determined in this study and GenBank reference isolates and other *G. lamblia* assemblages previously published ([Table 1](#T1){ref-type="table"}).

![Phylogenetic relationships of *G. lamblia* isolates in this study and reference isolates and other *G. lamblia* assemblages previously published in GenBank ([Table 1](#T1){ref-type="table"}) inferred by Neighbor-Joining analysis of Kimura's distances calculated based on the nucleotide sequences of *gdh* with the MEGA4 program. Bootstrap values \#50% are not shown. Accession numbers for reference sequences obtained from GenBank are given in parentheses. The sequence of *Giardia ardeae* was used as an out-group\
▲ is the indicator for Iranian isolates.](IJPA-12-522-g003){#F3}

The phylogenetic tree shows that assemblage A was the most frequent, corresponding with 32 cases (80%). All isolates in cluster A were distributed in sub-assemblage AII. The second cluster was contained the human assemblage B isolates. Assemblage B was found in 8 cases (20%) of the studied samples. Resulting in assemblage B revealed 2 major lineages designated as assemblages BIII and BIV. Third and fourth were the dog clusters of either assemblage C or D. The fifth cluster was contained the cattle assemblage E. The sixth was contained the cat assemblage F cluster. The seventh was contained the rodent assemblage G cluster. Finally, the eighth cluster was contained the *G. ardeae* ([Fig. 3](#F3){ref-type="fig"}). Phylogenetic analysis of the *gdh* gene of *G. lamblia* isolates from patients provided strong bootstrap support (100%) for the placement of genotypes A and B in separate clusters, indicating the differentiation of the assemblages A and B. Phylogenetic analysis has shown Fars isolates were widely distributed within assemblage A cluster (sub-assemblage AII) and the remaining Fars isolates were dispersed throughout the assemblage B cluster (sub-assemblage BIII and BIV). No samples were joined in clusters corresponding to assemblages C, D, E and F and G of *G. lamblia*, also in sub-assemblage AI.

Discussion
==========

Recent progressions on the identification of *Giardia* assemblages and sub-assemblages have increased tremendously in our understanding of the biology and host-parasite relationship of *G. lamblia*. In this study, 40 known *G. lamblia* isolates from patients were used to determine the sub-assemblages that occur in Fars province, Iran. All 40 *G. lamblia* isolates can be divided into four main groups based on the results obtained from this study. These groups are (i) sub-assemblage AII, (ii) sub-assemblage BIII, (iii) sub-assemblage BIV and (iv) sub-assemblage BIII/BIV as shown in [Table 2](#T2){ref-type="table"}. The sequences of *gdh* for the entire 40 *G. lamblia* patient isolates were compared to the sequences of known *G. lamblia* assemblages published by GenBank ([Table 1](#T1){ref-type="table"}).

In our study, three *G. lamblia* patient isolates were associated with sub-assemblage BIII and one isolate was associated with sub-assemblage BIV. Four isolates was situated between sub-assemblage BIII and BIV ([Table 2](#T2){ref-type="table"} and [Fig. 3](#F3){ref-type="fig"}). Additionally, Sequencing and phylogenetic analysis of *gdh* gene sequences from this study and a large set of those which were available from the literature worldwide showed the sequences of the 32 isolates associated with sub-assemblage AII were highly genetically homogenous with 100% homology to published sequences.

While the other eight isolates associated with sub-assemblages, BIII and BIV showed variability within the study area.

The results of this study are similar to previous studies ([@B9]--[@B11]) in which *G. lamblia* cysts isolated from human feces were analyzed with PCR-restriction fragment length polymorphism (RFLP) assay, based on the detection of glutamate dehydrogenase (*gdh*) genes. In Tehran, the capital of Iran a majority of 87% of the *G. lamblia* isolates used in the studies were from sub assemblage AII, whereas 7.8% of the isolates were from sub-assemblage BIII ([@B9]). Moreover, In Fars Province, 74.41% isolates were typed as assemblage AII, 17.44% as assemblage BIII, 3.49% as assemblage BIV and 4.66% isolates as mixed assemblages AII and BIV ([@B10]). In Isfahan Province in the center of Iran, PCRRFLP, genotype A group II was detected in 59.7% isolates compared to genotype B that showed 34.32% samples as genotype B Group III and 2.98% sample as genotype B group IV ([@B11]). In contrast with our study, assemblage B was predominant in Tabriz and Uremia cities in the northwest of Iran when the *gdh* gene was targeted by PCR RFLP. In Tabriz analysis, PCR-RFLP revealed that 28 samples (33.3%) were in sub-assemblage AII and 44.4% and 22.2% belonged to sub-assemblages BIII and BIV, respectively ([@B12]). In Uremia, 93.3% of isolates were found to be related to the genotype BIII and 6.7% were related to the subgroup BIV ([@B13]).

Current study had focused on the genetic characterization of *G. lamblia* at the *gdh* gene using DNA samples from patients' stool samples in Fars Province, Iran. Previous surveys performed on DNA extracted directly from fecal samples in various countries have confirmed that only *G. lamblia* assemblages A and B are associated with human infections ([@B25]). Genotypic analysis showed that only combination of assemblages AII and B are able to infect humans in this area of Iran, suggesting a human contamination origin. Most of our patients with sub-assemblage AII infection had acquired their parasites through the anthroponotic route, mainly involved human-to-human transmission. Zoonotic transmission may also occur. Reservoir sources of zoonotic transmission were found to be a number of livestock animal species like dairy cattle, companion animals like cats, dogs and wildlife animals ([@B26]). Unfortunately, due to limited funding, no animal sample was included in this study, so current result was not enough to demonstrate the role of anthroponotic and zoonotic aspects of giardiasis infections. Further molecular characterization of species, genotypes and subtyping analysis of specimens from both humans and animals and comparisons of various genetic loci are required for identification of the transmission of giardiasis between animals and humans and, understanding of giardiasis transmission.

Phylogenetic analysis of *G. lamblia* isolates from this study and previously published *G. lamblia* assemblages revealed two different clusters A and B. In cluster A there were two subclusters AI and AII. Within AI subcluster, three *G. lamblia* isolates Portland 1 (GenBank accession number: M84604-USA), F22 (EF507606-Brazil), and Ad-1 (AY178735-Australia) matched with reference isolate Ad-1(L40509-Australia). We did not have any sample of this study in this subcluster. Within subcluster AII, 32 homolog isolates of this study completely matched (GIS Group) with reference isolate Ad-2 (GenBank accession number: L40510-Australia). Moreover, other isolates Ad-113 (AY178736-Australia), TIG20 (AB434776-Iran), T11 (JF968202-Iran), 16 (JF917086-Iran), H32 (EF507674-Brazil), NLH20 (AY826194-Netherland) and GH-125 (AB195222-Japan) were in this subcluster. In cluster B there were two sub-clusters BIII and BIV with some subgroups that reveal variation in this assemblage. Within the BIII subcluster, reference isolate Bah12 (GenBank accession number: AF069059-Australia) and Fcq-21 (AY178756-Australia) matched in a subgroup. Isolates cub-G89 (EU594665-Cuba), cub-G81 (EU594667-Cuba), isolates gd-ber9 (DQ090540-Norway), gd-ber10 (DQ090541-Norway), and A14 (JF968198-Iran) did not match with Bah12. Moreover, the isolate GIS3 (this study) and TIG12 (AB434535-Iran) (in a subgroup) and 2 other isolates from this study GIS23 and GIS25 had variant with Bah12. In BIV sub cluster, Ad-28 (GenBank accession number: AY178738-Australia), Ad-45 (AY178739-Australia), H30 (EF507672-Brazil) and NLH13 (AY826191-Netherland) matched with reference isolate Ad7 (L40508-Australia). Isolate Ad-85 (AY178755-Australia) was found very close to this subgroup. Another two samples GH-158 (AB188825-Japan) and GH-156 (AB182126-Japan) (in a subgroup) and 5 of our samples GIS5, GIS31, GIS30 and GIS2 and GIS6 (in a subgroup), set far distance from reference isolate Ad7 in this subcluster. Analysis of the cluster B indicated genetic heterogeneity in assemblage B. On the other hand, separate samples from Japan, Cuba, Norway, and Iran having different sub category may suggest that in a country and in different countries in the world have different strains. Some isolates from this study (GIS23, GIS25, GIS2, GIS6, GIS30 and GIS31) that were very far distanced from the reference isolates in cluster B could be the new strains that need more investigations in future studies ([Table 1](#T1){ref-type="table"} and [Fig. 3](#F3){ref-type="fig"}).

Geographic distribution of each *Giardia* assemblage in humans varies in different parts of the world. Our results with predominance of assemblage A was same to studies from Brazil ([@B27]), Colombia ([@B28]), France ([@B29]), Iran ([@B9]), Italy ([@B30]), Mexico ([@B31]--[@B33]), New Zealand ([@B34]), Portugal ([@B3]), Thailand ([@B35]), United States ([@B36]) and Yemen ([@B37]). Some studies from Argentina ([@B38]), Australia ([@B39], [@B40]), Bangladesh ([@B41]), Belgium ([@B42]), Colombia ([@B43]), Egypt ([@B44], [@B45]), India ([@B46]), Malaysia ([@B47]), Morocco ([@B48]), Netherland ([@B4]), Nicaragua ([@B49]), Norway ([@B23], [@B50]), The Philippines ([@B51]), Thailand ([@B52]), United Kingdom ([@B2], [@B53]) and Sweden ([@B54]) with a predominance of assemblage B, differed from our study. Predominant *G. lamblia* sub-assemblage AII has also been shown in Australia ([@B6]), Bangladesh ([@B41]), Belgium ([@B42]), England ([@B2]), France ([@B55]), Iran ([@B13]), Mexico ([@B33]), Nicaragua ([@B49]), Peru ([@B56]) and The Philippines ([@B51]).

Conclusion
==========

Human giardiasis is one of the most common intestinal parasitic diseases in Iran, and its molecular epidemiology needs more investigations. PCR sequencing and phylogenetic analysis using the glutamate dehydrogenizes gene are proper molecular methods for *G. lamblia* genotyping and could discriminate *G. lamblia* sub-assemblages in fecal samples. The high prevalence of sub-assemblage AII in this study and other similar investigations conducted in Iran reemphasized the importance of applying all the health recommendations. Health education and improvement of sanitation conditions during drinking water and food supply are the most important basic strategies for the control and prevention of anthroponotic transmission of giardiasis in this community. The results could use in the future studies for clinical management and prevention policies.
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